EcoDrugPlus

Nt-3 Growth Factor Receptor-Like

Ensembl ID : ENSSTUG00000005163
Gene Symbol: LOC115151838
3 Cross references
198 Possible Orthologues:

Nt-3 Growth Factor Receptor-Like

Ensembl ID : ENSSTUG00000014517
Gene Symbol: LOC115196928
3 Cross references
198 Possible Orthologues:

P2x Purinoceptor 3-Like

Ensembl ID : ENSSTUG00000044919
Gene Symbol: LOC115191875
3 Cross references
189 Possible Orthologues:

P2x Purinoceptor 3-Like

Ensembl ID : ENSSTUG00000035165
Gene Symbol: LOC115202032
3 Cross references
190 Possible Orthologues:

P2x Purinoceptor 3-Like

Ensembl ID : ENSSTUG00000030421
Gene Symbol: LOC115204882
3 Cross references
186 Possible Orthologues:

P2x Purinoceptor 3-Like

Ensembl ID : ENSSTUG00000017514
Gene Symbol: LOC115171901
3 Cross references
185 Possible Orthologues:

P2x Purinoceptor 4-Like

Ensembl ID : ENSSTUG00000021560
Gene Symbol: LOC115164676
3 Cross references
185 Possible Orthologues:

P2x Purinoceptor 4-Like

Ensembl ID : ENSSTUG00000006988
Gene Symbol: LOC115199958
3 Cross references
185 Possible Orthologues:

P2y Purinoceptor 12-Like

Ensembl ID : ENSSTUG00000034650
Gene Symbol: LOC115206867
3 Cross references
174 Possible Orthologues:

P2y Purinoceptor 12-Like

Ensembl ID : ENSSTUG00000009527
Gene Symbol: LOC115163791
3 Cross references
174 Possible Orthologues:

Pim-3 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSSTUG00000030561
Gene Symbol: PIM3
3 Cross references
166 Possible Orthologues:

Pim-3 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSSTUG00000043883
Gene Symbol: PIM3
3 Cross references
166 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).